Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update
#Customers #Partners #Management Changes
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
#Investment #Partners #Customers
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
#Investment
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
#Investment
Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders
#Management Changes
Zacks.com featured highlights Lancaster Colony, On Holding, Rent the Runway, 5E Advanced Materials and Motus GI
#Investment
Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation
#Customers
There Are Reasons To Feel Uneasy About Motus Holdings' (JSE:MTH) Returns On Capital
#Investment
Investors in Motus Holdings (JSE:MTH) have seen splendid returns of 101% over the past three years
#Investment
Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering
#Investment #Public Trading
Did Motus Holdings Limited (JSE:MTH) Use Debt To Deliver Its ROE Of 19%?
#Investment
At R102, Is Motus Holdings Limited (JSE:MTH) Worth Looking At Closely?
#Investment
Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update
#Customers #Partners #Management Changes
Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update
#Investment #Management Changes
Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro
#Customers, Expand
We Take A Look At Why Motus Holdings Limited's (JSE:MTH) CEO Has Earned Their Pay Packet
#Management Changes
Motus GI Announces 1-for-15 Reverse Stock Split
#Public Trading #Management Changes
Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
#Customers, Expand
With 52% ownership of the shares, Motus Holdings Limited (JSE:MTH) is heavily dominated by institutional owners
#Investment
Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon
#Investment #Expand
Motus GI Amends Royalty Agreement
#Investment
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
#Management Changes
Motus Holdings Full Year 2023 Earnings: In Line With Expectations
#Customers #Investment
Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference
#Investment
Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update
#Customers #Management Changes #Layoffs
Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
#Customers #Expand
Motus Holdings (JSE:MTH) Is Reinvesting At Lower Rates Of Return
undefined
Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center
#Customers #Partners #Expand
Motus GI Holdings, Inc. (MOTS) Upgraded to Strong Buy: Here's What You Should Know
undefined
Lacklustre Performance Is Driving Motus Holdings Limited's (JSE:MTH) Low P/E
#Investment
If EPS Growth Is Important To You, Motus Holdings (JSE:MTH) Presents An Opportunity
undefined
Boasting A 23% Return On Equity, Is Motus Holdings Limited (JSE:MTH) A Top Quality Stock?
#Investment
Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center
#Partners
Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
#Management Changes
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
#Management Changes
Is Now The Time To Look At Buying Motus Holdings Limited (JSE:MTH)?
#Public Trading
Motus GI Announces $3.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
#Investment
Why Motus GI Stock Is Skyrocketing Today
#Customers
Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission
#Customers
Motus Holdings Limited (JSE:MTH) is a favorite amongst institutional investors who own 51%
#Investment
Motus GI Announces DDW 2023 Clinical Study Presentation Showing Pure-Vu EVS Drove a 33% Hospital-Wide Improvement in Incomplete Bowel Prep Rate at Minneapolis VA Medical Center
#Customers
Motus GI Reports First Quarter 2023 Financial Results and Provides Corporate Update
undefined
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates
undefined
Those who invested in Motus Holdings (JSE:MTH) three years ago are up 268%
#Public Trading
Angel Medical Systems, Creator of the Guardian™, First Implantable Cardiac Alert System, Changes Name to Avertix Medical Inc. and Welcomes New CEO and CFO to Drive Continued Growth and Success
#Customers #Management Changes
Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones
#Management Changes #Layoffs
Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
undefined
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
undefined
Motus GI Holdings Looks For Strategic Alternatives
#Layoffs #Management Changes
Motus GI Announces Exploration of Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring Plan
undefined
Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests
undefined
Motus GI Holdings Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
undefined
Motus GI Holdings, Inc. (MOTS) Reports Q3 Loss, Misses Revenue Estimates
undefined
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
#Customers #Expand
News Releases
#Management Changes #Investment
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
Motus GI and NYU Langone Health Partner to Improve its Inpatient Colonoscopy Management
#Partners
News Releases Motus GI Holdings, Inc.
#Management Changes
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
#Management Changes
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
#Management Changes
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
#Management Changes
News Releases Motus GI Holdings, Inc.
#Management Changes
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
#Management Changes
News Releases Motus GI Holdings, Inc.
undefined
News Releases Motus GI Holdings, Inc.
#Management Changes
Motus GI to Participate in Life Science Intelligence Emerging Medtech Summit 2020
undefined
Motus GI Announces EXPEDITE Study Initiated by Boston Medical Center to Evaluate Clinical Effectiveness of Pure-Vu® System for Improving Bowel Preparation Rates
undefined
Motus GI lands FDA clearance for next-gen colon prep system
#Customers #Expand
Motus GI Presents Positive Clinical Results from REDUCE Study Evaluating Pure-Vu® System in Hospitalized Colonoscopy Patients at Digestive Disease Week® 2019
undefined
Motus GI Announces Publication of Pure-Vu® System Clinical Study Data in Peer-Reviewed Journal of Clinical Gastroenterology
undefined
Motus GI Announces Publication of Pure-Vu® System Clinical Study Data in Peer-Reviewed Endoscopy Journal BioSpace
#Customers
Motus GI Announces $13.5 Million Follow-on Public Offering
undefined
Motus GI to Present at the Piper Jaffray Healthcare Conference
undefined
Motus GI Announces Successful Clinical Use of Pure-Vu® Slim Sleeve with Slim Colonoscopes
undefined
Motus GI Presents Positive Clinical Data from U.S. Prospective Study of the Pure-Vu® System at the 2018 American College of Gastroenterology (ACG) Annual Meeting
undefined
Motus GI Appoints Medical Device Commercial Leader Timothy P. Moran as Chief Executive Officer;Mark Pomeranz Continues in Key Executive Leadership Role as President and Chief Operating Officer
undefined
Motus GI Receives FDA Clearance to Market Pure-Vu® Slim Sleeve for Use with Slim Colonoscopes
undefined
Motus GI Appoints Jeff Hutchison as VP of U.S. Sales and Commercial Operations
#Management Changes #Expand
Motus GI Strengthens IP Portfolio with Issuance of Japanese Patent for the Pure-Vu® System
undefined
Motus GI Announces Inclusion in the Russell Microcap® Index
undefined
Motus GI's Pure-Vu System can lower repeated colonoscopy procedure cost by up to 82%
#Customers
Motus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized Patients
#Customers, Expand
Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® System
undefined
Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System
#Investment
Motus GI Announces Issuance of European Patent for the Pure-Vu® System
undefined
Motus GI Receives CE Mark Approval for the Pure-Vu® System
undefined
Motus GI Announces Closing of Initial Public Offering
undefined
Motus GI Holdings, Inc. Successfully Completes $30.0 Million Private Placement
#Investment
Motus GI touts Pure-Vu clinical data
#Customers
Pure-Vu Colonoscopy System for Cleansing Dirty Colons
#Customers
Device offering colonoscopy workaround to boost compliance wins FDA clearance
#Customers
FDA clears Pure-Vu System for intra-procedural colon cleaning: 3 notes
#Customers